(Q51983653)

19 April 2018

title

Amnestic mild cognitive impairment: diagnostic outcomes and clinical prediction over a two-year time period. (English)

1 reference

19 April 2018

mild cognitive impairment

main subject

1 reference

inferred from title

cognitive dysfunction

1 reference

H Randall Griffith

1

1 reference

19 April 2018

Kelli L Netson

2

1 reference

19 April 2018

Lindy E Harrell

3

1 reference

19 April 2018

Edward Y Zamrini

4

1 reference

19 April 2018

John C Brockington

5

1 reference

19 April 2018

Daniel C Marson

6

1 reference

19 April 2018

publication date

1 March 2006

1 reference

19 April 2018

Journal of the International Neuropsychological Society

published in

1 reference

19 April 2018

volume

12

1 reference

19 April 2018

issue

2

1 reference

19 April 2018

page(s)

166-175

1 reference

19 April 2018

Mild cognitive impairment, amnestic type: an epidemiologic study.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Predicting conversion to Alzheimer disease using standardized clinical information.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Progression to dementia in patients with isolated memory loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Early diagnosis of dementia: neuropsychology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Informed consent, competency, and the neurologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Independent predictors of cognitive decline in healthy elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Development and validation of a geriatric depression screening scale: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Five-Year Follow-up of Cognitive Impairment With No Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Cerebral blood flow in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Rates of progression in mild cognitive impairment and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

The Global Deterioration Scale for assessment of primary degenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

Donepezil for vascular cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

7 January 2021

Preclinical prediction of AD using neuropsychological tests

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

7 January 2021

Five-Year Outcomes for Dementia Defined Solely by Neuropsychological Test Performance

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

7 January 2021

Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

7 January 2021

Loss of Financial Competency in Dementia: Conceptual and Empirical Approaches

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

7 January 2021

CLOX: an executive clock drawing task

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

7 January 2021

Predictive value of APOE genotyping in incipient Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

7 January 2021

Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

7 January 2021

Do neuropsychological tests detect preclinical Alzheimer's disease: individual-test versus cognitive-discrepancy score analyses

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060267

7 January 2021

10.1017/S1355617706060267

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018